Sofroniew, 2009), which are closely related to glial scar formation
BPC-157 Body Protection Compound CAS: 137525-51-0 Formula: C 62 H 98 N 16 O 22 M.W.: 1419.556 g/mol Purity: 99%+ Ref No.:BOC-0005VI Ref No.:BOC-0010VI For Research Use Only (RUO) Not for human or veterinary use
Two observational studies reported similar high rates of efficacy, including significant pain relief in 91% of patients after six weeks of treatment accompanied by decreases in frequency and increases in voided volumes 144 and after an average one year of treatment, 87% of patients reporting that they were pain-free with similar improvements in voiding parameters
Methods A systematic review of the literature using the MEDLINE database (search dates 1/1/83-7/22/09) was conducted to identify peer-reviewed publications relevant to the diagnosis and treatment of IC/BPS
In short, the signs and symptoms of aging (fatigue, brain fog, slower recovery, visible skin changes) often trace back to reduced NAD+ availability
BPC Wolverine accelerates healing and recovery